Learn More
CD267 Rat anti-Human, PE, Clone: 1A1-K21-M22, BD
Rat Monoclonal Antibody
Supplier: BD Biosciences 558414
Description
The 1A1-K21-M22 monoclonal antibody specifically binds to CD267 which is also known as TACI (Transmembrane Activator and CAML Interactor). CD267 is a member of the of the Tumor Necrosis Factor Receptor (TNFR) Superfamily and is encoded by the TNFRSF13B gene. This 32 kDa type III transmembrane protein receptor binds to the ligands, BAFF (TNFSF13B/BLyS/CD257) and APRIL (TNFSF13/CD256). Ligand-bound CD267 transduces signals leading to the activation of transcription factors including NFAT, AP1, and NF-kappa-B. CD267 is expressed most notably on maturing subsets of B cells and myeloma cells. In CD267 deficient mice, B cell numbers are increased and mice develop autoimmune disorders suggesting that CD267 plays an important role in the regulation of B cell homeostasis.

Specifications
CD267 | |
Monoclonal | |
0.2mg/mL | |
TACI; TNFRSF13B; Tumor necrosis factor receptor 13B; TNFRSF14B2; CVID2 | |
Rat | |
0.1 mg | |
Immunology | |
Human | |
IgG2a κ |
Flow Cytometry | |
1A1-K21-M22 | |
PE | |
Aqueous buffered solution containing ≤0.09% sodium azide. | |
Human RBL | |
RUO | |
Primary | |
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.